Senores Pharmaceuticals Limited (NSE:SENORES)
India · Delayed Price · Currency is INR 1,113.00
+3.65 (0.33%)
May 22, 2026, 3:30 PM IST
Senores Pharmaceuticals Revenue
In the fiscal year ending March 31, 2026, Senores Pharmaceuticals had annual revenue of 6.80B INR with 70.67% growth. Senores Pharmaceuticals had revenue of 1.93B in the quarter ending March 31, 2026, with 68.86% growth.
Revenue
6.80B
Revenue Growth
+70.67%
P/S Ratio
8.09
Revenue / Employee
32.61M
Employees
194
Market Cap
51.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.80B | 2.81B | 70.67% |
| Mar 31, 2025 | 3.98B | 1.84B | 85.65% |
| Mar 31, 2024 | 2.15B | 1.79B | 507.07% |
| Mar 31, 2023 | 353.37M | 211.67M | 149.38% |
| Mar 31, 2022 | 141.70M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 604.34B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 103.14B |
| Entero Healthcare Solutions | 60.20B |
| Sun Pharma Advanced Research Company | 18.90B |
| Aarti Pharmalabs | 18.01B |
| Innova Captab | 16.37B |